Treatment biomarkers for ADHD: Taking stock and moving forward

The development of treatment biomarkers for psychiatric disorders has been challenging, particularly for heterogeneous neurodevelopmental conditions such as attention-deficit/hyperactivity disorder (ADHD). Promising findings are also rarely translated into clinical practice, especially with regard t...

Descripción completa

Detalles Bibliográficos
Autores principales: Michelini, Giorgia, Norman, Luke J., Shaw, Philip, Loo, Sandra K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9556670/
https://www.ncbi.nlm.nih.gov/pubmed/36224169
http://dx.doi.org/10.1038/s41398-022-02207-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9556670/
https://www.ncbi.nlm.nih.gov/pubmed/36224169
http://dx.doi.org/10.1038/s41398-022-02207-2

Ejemplares similares